Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data

Deborah L. Gregory, Rodney J. Hicks, Annette Hogg, David S. Binns, Poh Lin Shum, Alvin Milner, Emma Link, David L Ball and Michael P. Mac Manus
Journal of Nuclear Medicine July 2012, 53 (7) 1007-1015; DOI: https://doi.org/10.2967/jnumed.111.099713
Deborah L. Gregory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodney J. Hicks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Hogg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Binns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Poh Lin Shum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvin Milner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Link
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L Ball
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Mac Manus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Survival according to stage groupings determined by conventional imaging (top) or PET/CT (bottom). Est = estimated.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Survival curves for 100 patients found to have anatomically resectable disease by conventional imaging (stage I or II) according to their conventional imaging stage (top) or their PET/CT stage (bottom), showing prognostic stratification only by PET/CT stage. Est = estimated.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    OS by treatment actually received for 131 patients managed according to stated post-PET/CT plan. Est = estimated.

Tables

  • Figures
    • View popup
    TABLE 1.

    Comparison of Conventional Imaging and PET Stages

    PET stage group
    Conventional imaging stage group01A1B2A2B3A3B4TotalDownstagedUpstaged
    00000000000 (0)0 (0.0)
    1A224310319432 (4.7)17 (39.5)
    1B001908446410 (0.0)22 (53.7)
    2A1000020141 (25.0)3 (75.0)
    2B00009201120 (0.0)3 (25.0)
    3A0041314910418 (19.5)19 (46.3)
    3B01001195173 (17.6)5 (29.4)
    400001018102 (20.0)0 (0.0)
    Total16 (10)69 (41.1)
    • Data in parentheses are percentages.

    • View popup
    TABLE 2

    Impact of PET/CT on Patient Management Plan

    Before PET/CTAfter PET/CTPET/CT impact
    Management planNo. of patientsManagement planNo. of patientsHighMediumLowNone
    Observation1Surgery11000
    Invasive biopsy28Invasive biopsy919090
    Observation1
    Surgical9
    Radical RT*3
    Palliative†6
    Surgery80Surgery54260504
    Diagnostic (invasive biopsy)2
    Observation2
    Radical RT‡8
    Radical RT, for both NSCLC and PET-detected pharynx cancer1
    Palliative§13
    Radical RT49Radical RT as planned∥19237181
    Radical CRT, field increased6
    Radical CRT, field decreased1
    Surgery4
    Induction chemotherapy, followed by surgery1
    Palliative chemotherapy or RT¶18
    Palliative10Palliative chemotherapy or RT, as planned#82260
    Palliative CRT, RT field increased2
    Total16816871 (42%)9 (5%)83 (49%)5 (3%)
    • ↵* Radical RT no chemotherapy (n = 1), radical CRT (n = 2).

    • ↵† Palliative chemotherapy and RT (n = 5), chemotherapy (n = 1).

    • ↵‡ Radical RT alone (n = 1), radical CRT (n = 7).

    • ↵§ Palliative chemotherapy and RT (n = 10), chemotherapy only (n = 2), expectant palliative (n = 1).

    • ↵∥ Radical RT (n = 5), radical CRT (n = 14).

    • ↵¶ Palliative chemotherapy and RT (n = 17).

    • ↵# Palliative chemotherapy and RT (n = 5), chemotherapy only (n = 3).

    • CRT = chemotherapy and radiation therapy.

    • View popup
    TABLE 3.

    Impact of PET/CT by Conventional Imaging Stage Group

    Conventional imaging stage groupNo. of cases% of casesHigh% highLow% lowMedium% mediumNone% none
    18450.03136.95160.700.022.4
    2169.5637.51062.500.000.0
    35834.53051.71729.3915.523.4
    4106.0440.0550.000.0110.0
    Total1681007142.38248.895.463.6
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (7)
Journal of Nuclear Medicine
Vol. 53, Issue 7
July 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data
Deborah L. Gregory, Rodney J. Hicks, Annette Hogg, David S. Binns, Poh Lin Shum, Alvin Milner, Emma Link, David L Ball, Michael P. Mac Manus
Journal of Nuclear Medicine Jul 2012, 53 (7) 1007-1015; DOI: 10.2967/jnumed.111.099713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data
Deborah L. Gregory, Rodney J. Hicks, Annette Hogg, David S. Binns, Poh Lin Shum, Alvin Milner, Emma Link, David L Ball, Michael P. Mac Manus
Journal of Nuclear Medicine Jul 2012, 53 (7) 1007-1015; DOI: 10.2967/jnumed.111.099713
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Radiation exposure during lung cancer diagnostic work-up: how important in the wider picture?
  • Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients
  • Let's Get SEERious: More Accurate Staging With Consequent High Management Impact Is Not Just Stage Migration
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire